AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29
Ifosfamide and mitoxantrone in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck
Authors: Thurnher, D Kornfehl, J Burian, M Gedlicka, C Selzer, E Quint, C Neuchrist, C Kornek, GV
Citation: D. Thurnher et al., Ifosfamide and mitoxantrone in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck, ANTI-CANC D, 12(3), 2001, pp. 205-208
Multicenter phase II trial of dose-fractionated irinotecan in patients with advanced colorectal cancer failing oxaliplatin-based first-line combination chemotherapy
Authors: Ulrich-Pur, H Kornek, GV Fiebiger, W Gedlicka, C Raderer, M Lenauer, A Depisch, D Lang, F Pidlich, J Scheithauer, W
Citation: H. Ulrich-pur et al., Multicenter phase II trial of dose-fractionated irinotecan in patients with advanced colorectal cancer failing oxaliplatin-based first-line combination chemotherapy, ANN ONCOL, 12(9), 2001, pp. 1269-1272
Second-line treatment with oxaliplatin plus raltitrexed in patients with advanced colorectal cancer failing fluoropyrimidine/leucovorin-based chemotherapy
Authors: Scheithauer, W Kornek, GV Schuell, B Ulrich-Pur, H Penz, M Raderer, M Lang, F Schneeweiss, B Lenauer, A Depisch, D
Citation: W. Scheithauer et al., Second-line treatment with oxaliplatin plus raltitrexed in patients with advanced colorectal cancer failing fluoropyrimidine/leucovorin-based chemotherapy, ANN ONCOL, 12(5), 2001, pp. 709-714
Subcutaneous administration of amifostine: A promising therapeutic option in patients with oxaliplatin-related peripheral sensitive neuropathy
Authors: Penz, M Kornek, GV Raderer, M Ulrich-Pur, H Fiebiger, W Scheithauer, W
Citation: M. Penz et al., Subcutaneous administration of amifostine: A promising therapeutic option in patients with oxaliplatin-related peripheral sensitive neuropathy, ANN ONCOL, 12(3), 2001, pp. 421-422
Phase II trial of two-weekly gemcitabine in patients with advanced biliarytract cancer
Authors: Penz, M Kornek, GV Raderer, M Ulrich-Pur, H Fiebiger, W Lenauer, A Depisch, D Krauss, G Schneeweiss, B Scheithauer, W
Citation: M. Penz et al., Phase II trial of two-weekly gemcitabine in patients with advanced biliarytract cancer, ANN ONCOL, 12(2), 2001, pp. 183-186
Idiosyncratic reaction after oxaliplatin: Circumvention by use of a continuous infusional administration schedule
Authors: Schull, B Kornek, GV Scheithauer, W
Citation: B. Schull et al., Idiosyncratic reaction after oxaliplatin: Circumvention by use of a continuous infusional administration schedule, ANN ONCOL, 12(11), 2001, pp. 1653-1654
Treatment of advanced breast cancer with vinorelbine and docetaxel with orwithout human granulocyte colony-stimulating factor
Authors: Kornek, GV Ulrich-Pur, H Penz, M Haider, K Kwasny, W Depisch, D Kovats, E Lang, F Schneeweiss, B Scheithauer, W
Citation: Gv. Kornek et al., Treatment of advanced breast cancer with vinorelbine and docetaxel with orwithout human granulocyte colony-stimulating factor, J CL ONCOL, 19(3), 2001, pp. 621-627
Cancer treatment in the elderly
Authors: Kornek, GV
Citation: Gv. Kornek, Cancer treatment in the elderly, ONKOLOGIE, 24(5), 2001, pp. 499-504
Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx
Authors: Glaser, CM Millesi, W Kornek, GV Lang, S Schull, B Watzinger, F Selzer, E Lavey, RS
Citation: Cm. Glaser et al., Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx, INT J RAD O, 50(3), 2001, pp. 705-715
Combined radiochemotherapy of locally advanced unresectable pancreatic adenocarcinoma with mitomycin C plus 24-hour continuous infusional gemcitabine
Authors: Kornek, GV Potter, R Selzer, E Schratter, A Ulrich-Pur, H Rogy, M Kraus, G Scheithauer, W
Citation: Gv. Kornek et al., Combined radiochemotherapy of locally advanced unresectable pancreatic adenocarcinoma with mitomycin C plus 24-hour continuous infusional gemcitabine, INT J RAD O, 49(3), 2001, pp. 665-671
Treatment of advanced hepatocellular carcinoma with biweekly high-dose gemcitabine
Authors: Ulrich-Pur, H Kornek, GV Fiebiger, W Schull, B Raderer, M Scheithauer, W
Citation: H. Ulrich-pur et al., Treatment of advanced hepatocellular carcinoma with biweekly high-dose gemcitabine, ONCOL-BASEL, 60(4), 2001, pp. 313-315
Oxaliplatin-induced fever and release of IL-6 (vol 59, pg 187, 2000)
Authors: Ulrich-Pur, H Penz, M Fiebiger, WCC Schull, B Kornek, GV Scheithauer, W Raderer, M
Citation: H. Ulrich-pur et al., Oxaliplatin-induced fever and release of IL-6 (vol 59, pg 187, 2000), ONCOL-BASEL, 60(2), 2001, pp. 145-145
Oxaliplatin plus raltitrexed in patients with advanced colorectal carcinoma - Results of a phase I-II trial
Authors: Scheithauer, W Kornek, GV Ulrich-Pur, H Penz, M Raderer, M Salek, T Haider, K Kwasny, W Depisch, D
Citation: W. Scheithauer et al., Oxaliplatin plus raltitrexed in patients with advanced colorectal carcinoma - Results of a phase I-II trial, CANCER, 91(7), 2001, pp. 1264-1271
Treatment of hepatocellular cancer with the long acting somatostatin analog lanreotide in vitro and in vivo
Authors: Raderer, M Hejna, MHL Muller, C Kornek, GV Kurtaran, A Virgolini, I Fiebieger, W Hamilton, G Scheithauer, W
Citation: M. Raderer et al., Treatment of hepatocellular cancer with the long acting somatostatin analog lanreotide in vitro and in vivo, INT J ONCOL, 16(6), 2000, pp. 1197-1201
Locally advanced head and neck cancer: Modern concepts for therapy
Authors: Kornek, GV Schratter-Sehn, AU Burian, M
Citation: Gv. Kornek et al., Locally advanced head and neck cancer: Modern concepts for therapy, ONKOLOGIE, 23(2), 2000, pp. 177-182
Oxaliplatin-induced fever and release of IL-6
Authors: Ulrich-Pur, H Fiebiger, WCC Schull, B Kornek, GV Scheithauer, W Raderer, M
Citation: H. Ulrich-pur et al., Oxaliplatin-induced fever and release of IL-6, ONCOL-BASEL, 59(3), 2000, pp. 187-189
Treatment of patients with advanced nonsmall cell lung carcinoma using docetaxel and gemcitabine plus granulocyte-colony stimulating factor
Authors: Hejna, M Kornek, GV Raderer, M Ulrich-Pur, H Fiebiger, WCC Marosi, L Schneeweiss, B Greul, R Scheithauer, W
Citation: M. Hejna et al., Treatment of patients with advanced nonsmall cell lung carcinoma using docetaxel and gemcitabine plus granulocyte-colony stimulating factor, CANCER, 89(3), 2000, pp. 516-522
A phase II trial of biweekly high dose gemcitabine for patients with metastatic pancreatic adenocarcinoma
Authors: Ulrich-Pur, H Kornek, GV Raderer, M Haider, K Kwasny, W Depisch, D Greul, R Schneeweiss, B Krauss, G Funovics, J Scheithauer, W
Citation: H. Ulrich-pur et al., A phase II trial of biweekly high dose gemcitabine for patients with metastatic pancreatic adenocarcinoma, CANCER, 88(11), 2000, pp. 2505-2511
Treatment of unresectable, locally advanced pancreatic adenocarcinoma withcombined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin
Authors: Kornek, GV Schratter-Sehn, A Marczell, A Depisch, D Karner, J Krauss, G Haider, K Kwasny, W Locker, G Scheithauer, W
Citation: Gv. Kornek et al., Treatment of unresectable, locally advanced pancreatic adenocarcinoma withcombined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin, BR J CANC, 82(1), 2000, pp. 98-103
Combined irinotecan and oxaliplatin plus granulocyte colony-stimulating factor in patients with advanced fluoropyrimidine/leucovorin-pretreated colorectal cancer
Authors: Scheithauer, W Kornek, GV Raderer, M Valencak, J Weinlander, G Hejna, M Haider, K Kwasny, W Depisch, D
Citation: W. Scheithauer et al., Combined irinotecan and oxaliplatin plus granulocyte colony-stimulating factor in patients with advanced fluoropyrimidine/leucovorin-pretreated colorectal cancer, J CL ONCOL, 17(3), 1999, pp. 902-906
Gemcitabine for the treatment of advanced biliary tract carcinomas: Evaluation of two different dose regimens
Authors: Valencak, J Kornek, GV Raderer, M Ulrich-Pur, H Krauss, G Greul, R Pidlich, J Pfeffel, F Haider, K Kwasny, W Schneeweiss, B Scheithauer, W
Citation: J. Valencak et al., Gemcitabine for the treatment of advanced biliary tract carcinomas: Evaluation of two different dose regimens, ONKOLOGIE, 22(6), 1999, pp. 498-501
Treatment of advanced gastric cancer with oral idarubicin, leucovorin, andtegafur
Authors: Ulrich-Pur, H Raderer, M Kornek, GV Haider, K Kwasny, W Krauss, G Scheithauer, W
Citation: H. Ulrich-pur et al., Treatment of advanced gastric cancer with oral idarubicin, leucovorin, andtegafur, ONKOLOGIE, 22(4), 1999, pp. 292-294
Treatment of advanced breast cancer with gemcitabine and vinorelbine plus human granulocyte colony-stimulating factor
Authors: Haider, K Kornek, GV Kwasny, W Weinlander, G Valencak, J Lang, F Puribauer, F Kovats, E Depisch, D Scheithauer, W
Citation: K. Haider et al., Treatment of advanced breast cancer with gemcitabine and vinorelbine plus human granulocyte colony-stimulating factor, BREAST CANC, 55(3), 1999, pp. 203-211
Two consecutive phase II studies of 5-fluorouracil leucovorin mitomycin C and of gemcitabine in patients with advanced biliary cancer
Authors: Raderer, M Hejna, MHL Valencak, JB Kornek, GV Weinlander, GS Bareck, E Lenauer, J Brodowicz, T Lang, F Scheithauer, W
Citation: M. Raderer et al., Two consecutive phase II studies of 5-fluorouracil leucovorin mitomycin C and of gemcitabine in patients with advanced biliary cancer, ONCOL-BASEL, 56(3), 1999, pp. 177-180
Phase II trial of gemcitabine, epirubicin and granulocyte colony-stimulating factor in patients with advanced pancreatic adenocarcinoma
Authors: Scheithauer, W Kornek, GV Raderer, M Hejna, M Valencak, J Miholic, J Kovats, E Lang, F Funovics, J Bareck, E Depisch, D
Citation: W. Scheithauer et al., Phase II trial of gemcitabine, epirubicin and granulocyte colony-stimulating factor in patients with advanced pancreatic adenocarcinoma, BR J CANC, 80(11), 1999, pp. 1797-1802
Risultati: 1-25 | 26-29